West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
272.54
+3.88 (1.44%)
At close: Dec 19, 2025, 4:00 PM EST
274.23
+1.69 (0.62%)
After-hours: Dec 19, 2025, 5:24 PM EST
WST Revenue
West Pharmaceutical Services had revenue of $804.60M in the quarter ending September 30, 2025, with 7.73% growth. This brings the company's revenue in the last twelve months to $3.02B, up 4.92% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$3.02B
Revenue Growth
+4.92%
P/S Ratio
6.54
Revenue / Employee
$284,708
Employees
10,600
Market Cap
19.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
| Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
| Dec 31, 2018 | 1.72B | 118.30M | 7.40% |
| Dec 31, 2017 | 1.60B | 90.00M | 5.96% |
| Dec 31, 2016 | 1.51B | 109.30M | 7.81% |
| Dec 31, 2015 | 1.40B | -21.60M | -1.52% |
| Dec 31, 2014 | 1.42B | 53.00M | 3.87% |
| Dec 31, 2013 | 1.37B | 102.00M | 8.05% |
| Dec 31, 2012 | 1.27B | 74.10M | 6.21% |
| Dec 31, 2011 | 1.19B | 87.60M | 7.93% |
| Dec 31, 2010 | 1.10B | 49.00M | 4.64% |
| Dec 31, 2009 | 1.06B | 4.60M | 0.44% |
| Dec 31, 2008 | 1.05B | 31.00M | 3.04% |
| Dec 31, 2007 | 1.02B | 106.80M | 11.69% |
| Dec 31, 2006 | 913.30M | 213.60M | 30.53% |
| Dec 31, 2005 | 699.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
WST News
- 7 days ago - West to Participate in Upcoming Investor Conference - PRNewsWire
- 9 days ago - West Declares Quarterly Dividend - PRNewsWire
- 10 days ago - Top 50 High-Quality Dividend Growth Stocks For December 2025 - Seeking Alpha
- 17 days ago - West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 18 days ago - West Pharmaceutical: Back To Growth - Seeking Alpha
- 20 days ago - Best Dividend Aristocrats For December 2025 - Seeking Alpha
- 4 weeks ago - West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha